CIK 0001484612
- Accelerated filer
- Smaller reporting company
Outset Medical, Inc.
Sign in to watch- Ticker
- OM
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 200514392
- Phone
- +1 669-231-8200
- Business address
- 3052 ORCHARD DRIVE, SAN JOSE, CA, 95134
- Former names
- Home Dialysis Plus, Ltd.
- Open-market buys, last 90 days
- $870,260
- in 1 filing
- Open-market sales, last 90 days
- $28,997
- in 2 filings
Net +$841,264. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 50 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-17 | Trigg Leslie Chair and CEO | Sale | −909 | $26.36 | $24K | 292,073 |
| 2022-05-17 | Porter Stacey L. Chief People Officer | Sale | −105 | $26.36 | $3K | 30,801 |
| 2022-05-17 | Ahmed Nabeel Chief Financial Officer | Sale | −120 | $26.36 | $3K | 44,369 |
| 2022-05-17 | Brottem John L. General Counsel | Sale | −349 | $26.36 | $9K | 33,665 |
| 2022-05-02 | Ahmed Nabeel Chief Financial Officer | Exercise or conversion | +200 | $9.48 | $2K | 44,689 |
| 2022-05-02 | Ahmed Nabeel Chief Financial Officer | Sale | −200 | $35.00 | $7K | 44,489 |
| 2022-05-02 | Ahmed Nabeel Chief Financial Officer | Exercise or conversion · Performance Options (right to buy) | −200 | 10,132 | ||
| 2022-05-02 | Vazquez Martin Chief Operating Officer | Exercise or conversion | +5,000 | $3.88 | $19K | 54,495 |
| 2022-05-02 | Vazquez Martin Chief Operating Officer | Sale | −5,000 | $35.58 | $178K | 49,495 |
| 2022-05-02 | Vazquez Martin Chief Operating Officer | Exercise or conversion · Performance Options (right to buy) | −5,000 | 113,007 | ||
| 2022-05-02 | Trigg Leslie Chair and CEO | Exercise or conversion | +30,000 | $3.88 | $116K | 322,982 |
| 2022-05-02 | Trigg Leslie Chair and CEO | Sale | −30,000 | $35.87 | $1.1M | 292,982 |
| 2022-05-02 | Trigg Leslie Chair and CEO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −30,000 | 15,711 | ||
| 2022-04-21 | JONES DALE E Director | Grant or award | +6,357 | 6,357 | ||
| 2022-04-18 | Brottem John L. General Counsel | Exercise or conversion | +1,000 | $9.48 | $9K | 35,014 |
| 2022-04-18 | Brottem John L. General Counsel | Sale | −1,000 | $43.25 | $43K | 34,014 |
| 2022-04-18 | Brottem John L. General Counsel | Exercise or conversion | +1,415 | $9.48 | $13K | 35,429 |
| 2022-04-18 | Brottem John L. General Counsel | Sale | −1,415 | $43.25 | $61K | 34,014 |
| 2022-04-18 | Brottem John L. General Counsel | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −1,415 | 38,223 | ||
| 2022-04-18 | Brottem John L. General Counsel | Exercise or conversion · Performance Options (right to buy) | −1,000 | 2,265 |
Page 21 of 34 · 678 trades